p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition

Neoplasia (United States)

Volumn 14, Issue 12, 2012, Pages 1269-1277

  Al Ansari, Mysoon M ^a   Hendrayani, Siti Fauziah ^a   Tulbah, Asma ^a   Al Tweigeri, Taher ^a   Shehata, Afaf I ^b   Aboussekhra, Abdelilah ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; PROTEIN P16; SMALL INTERFERING RNA; VASCULOTROPIN A; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; TARGET OF RAPAMYCIN KINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; AUTOCRINE EFFECT; BREAST TUMOR; CELL DIFFERENTIATION; CELL MOTION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OPEN READING FRAME; PARACRINE SIGNALING; PATHOLOGY; SECRETION (PROCESS); STROMA CELL; TUMOR CELL CULTURE; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; FIBROBLASTS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; NEOVASCULARIZATION, PATHOLOGIC; OPEN READING FRAMES; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STROMAL CELLS; TOR SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MLCS; MLOWN;

EID: 84871553346     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121632     Document Type: Article

References (41)

1. Aboussekhra A (2011). Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol 55, 841-849.
2. Shimoda M, Mellody KT, and Orimo A (2009). Carcinoma-associated fibro blasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 21, 19-25.
3. Franco OE, Shaw AK, Strand DW, and Hayward SW (2009). Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 21, 33-39.
4. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, and Weinberg RA (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
5. Bergers G and Benjamin LE (2003). Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3, 401-410.
6. Carmeliet P (2005). VEGF as a key mediator of angiogenesis in cancer. Oncology 69(suppl 3), 4-10.
7. Pinto MP, Badtke MM, Dudevoir ML, Harrell JC, Jacobsen BM, and Horwitz KB (2010). Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor positive breast cancer. Cancer Res 70, 2655-2664.
8. Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, et al. (1997). Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 89, 139-147.
9. Jiang BH and Liu LZ (2008). AKT signaling in regulating angiogenesis. Curr Cancer Drug Targets 8, 19-26.
10. Xin H, Brown JA, Gong C, Fan H, Brewer G, and Gnarra JR (2012). Association of the von Hippel-Lindau protein with AUF1 and posttranscriptional regulation of VEGFA mRNA. Mol Cancer Res 10, 108-120.
11. Merdzhanova G, Gout S, Keramidas M, Edmond V, Coll JL, Brambilla C, Brambilla E, Gazzeri S, and Eymin B (2010). The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo. Oncogene 29, 5392-5403.
12. Essafi-Benkhadir K, Onesto C, Stebe E, Moroni C, and Pages G (2007). Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol Biol Cell 18, 4648-4658.
13. Okamoto K, Kamibayashi C, Serrano M, Prives C, Mumby MC, and Beach D (1996). p53-dependent association between cyclin G and the B′ subunit of protein phosphatase 2a. Mol Cell Biol 16, 6593-6602.
14. INK4a gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 23, 201-212.
15. Bae I, Smith ML, Sheikh MS, Zhan Q, Scudiero DA, Friend SH, O'Connor PM, and Fornace AJ Jr (1996). An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. Cancer Res 56, 840-847.
16. INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J Med Invest 51, 146-153.
17. INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378, F115-F177.
18. Rocco JW and Sidransky D (2001). p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264, 42-55.
19. INK4A and their relevance to cancer. Biochemistry 50, 5566-5582.
20. INK4A represses the paracrine tumor-promoting effects of breast stromal fibroblasts. Oncogene. DOI:10.1038/onc.2012.270.
21. Hawsawi NM, Ghebeh H, Hendrayani SF, Tulbah A, Al-Eid M, Al-Tweigeri T, Ajarim D, Alaiya A, Dermime S, and Aboussekhra A (2008). Breast carcinoma associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 68, 2717-2725.
22. Arf predisposes mice to tumorigenesis. Nature 413, 86-91.
23. WAF1 induction in response to ultraviolet light. Nucleic Acids Res 35, 223-233.
24. Vong S and Kalluri R (2011). The role of stromal myofibroblast and extra cellular matrix in tumor angiogenesis. Genes Cancer 2, 1139-1145.
25. INK4a inhibits both CDK4 and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol Cell Biol 19, 1981-1989.
26. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, and Toker A (2005). Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20, 539-550.
27. Skinner HD, Zheng JZ, Fang J, Agani F, and Jiang BH (2004). Vascular endothelial growth factor transcriptional activation is mediated by hypoxia inducible factor 1α, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling. J Biol Chem 279, 45643-45651.
28. Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721-732.
29. Allen M and Louise Jones J (2011). Jekyll and Hyde: the role of the micro environment on the progression of cancer. J Pathol 223, 162-176.
30. Li M, Zhang Z, Hill DL, Wang H, and Zhang R (2007). Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res 67, 1988-1996.
31. Harada H, Nakagawa K, Iwata S, Saito M, Kumon Y, Sakaki S, Sato K, and Hamada K (1999). Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. Cancer Res 59, 3783-3789.
32. Jiang BH and Liu LZ (2008). PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784, 150-158.
33. Semenza GL (2010). HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20, 51-56.
34. Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene 30, 2087-2097.
35. ink4a expression in tumors: functional significance, clinical associations and future developments. Cell Cycle 10, 2497-2503.
36. ink4a-binding proteins. Proteomics 7, 4102-4111.
37. INK4a synergistically regulate cell cycle progression and E2F1-responsive gene expression. J Biol Chem 285, 27545-27552.
38. INK4a positively regulates cyclin D1 and E2F1 through negative control of AUF1. PLoS One 6, e21111.
39. INK4a at the post-transcriptional level through the microRNA pathway. Oncogene 30, 1880-1891.
40. INK4a promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 63, 1596-1601.
41. INK4a overexpress COX-2, promoting a premalignant program. Cancer Cell 5, 263-273.